Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 13(7): e0197806, 2018.
Article in English | MEDLINE | ID: mdl-30001321

ABSTRACT

Polymeric biomaterials composed of extracellular matrix components possess osteoconductive capacity that is essential for bone healing. The presence of collagen and the ability to undergo physicochemical modifications render these materials a suitable alternative in bone regenerative therapies. The objective of this study was to evaluate the osteogenic capacity of collagen-based matrices (native and anionic after alkaline hydrolysis) made from bovine intestinal serosa (MBIS). Twenty-five animals underwent surgery to create a cranial defect to be filled with native and anionic collagen matrixes, mmineralized and non mineralized. The animals were killed painlessly 6 weeks after surgery and samples of the wound area were submitted to routine histology and morphometric analysis. In the surgical area there was new bone formation projecting from the margins to the center of the defect. More marked bone neoformation occurred in the anionic matrices groups in such a way that permitted union of the opposite margins of the bone defect. The newly formed bone matrix exhibited good optical density of type I collagen fibers. Immunoexpression of osteocalcin by osteocytes was observed in the newly formed bone. Morphometric analysis showed a greater bone volume in the groups receiving the anionic matrices compared to the native membranes. Mineralization of the biomaterial did not increase its osteoregenerative capacity. In conclusion, the anionic matrix exhibits osteoregenerative capacity and is suitable for bone reconstruction therapies.


Subject(s)
Bone Regeneration/drug effects , Collagen/pharmacology , Extracellular Matrix/transplantation , Intestines/chemistry , Serous Membrane/chemistry , Skull Fractures/drug therapy , Animals , Biomarkers/metabolism , Bone Regeneration/physiology , Calcification, Physiologic/physiology , Cattle , Collagen/chemistry , Collagen/isolation & purification , Gene Expression , Osteocalcin/genetics , Osteocalcin/metabolism , Osteogenesis/drug effects , Osteogenesis/genetics , Rats , Rats, Wistar , Skull/drug effects , Skull/injuries , Skull/pathology , Skull Fractures/pathology , Wound Healing/drug effects
2.
AAPS PharmSciTech ; 9(3): 762-8, 2008.
Article in English | MEDLINE | ID: mdl-18563577

ABSTRACT

The purpose of this research was the preparation of four formulations containing hydrocortisone acetate (HCA) for topical application, including two aqueous systems (hydrophilic microemulsion and aqueous gel) and two systems with dominant hydrophobicity (hydrophobic microemulsion and ointment). The formulations were tested for the release and permeation of HCA across an animal membrane. The release of HCA was found comparable for the four systems. The two microemulsions promote permeation across an ex-vivo membrane, examined by means of a Franz cell. Hydrophobic microemulsion guarantees the highest solubility (2,370 microg/ml) and flux (133 microg/cm(2).h) of the drug, since it contains almost 40% Transcutol, a permeation enhancer. Gel and ointment provide lower solubility and flux, being the values, related to the ointment, the lowest ones (562 microg/ml and 0.4 microg/cm(2).h). Experimental results allow the conclusion that gel and ointment can be suitable when it is desirable to minimize absorption of topically applied HCA as to keep the drug restricted to the diseased area and prevent side effects of the systemic presence of HCA.


Subject(s)
Hydrocortisone/analogs & derivatives , Skin Absorption/drug effects , Administration, Cutaneous , Animals , Chemistry, Pharmaceutical , Delayed-Action Preparations , Hydrocortisone/administration & dosage , Hydrocortisone/chemistry , Lipids , Skin Absorption/physiology , Swine
3.
Eur J Pharm Biopharm ; 69(1): 335-41, 2008 May.
Article in English | MEDLINE | ID: mdl-18182280

ABSTRACT

Eight formulations were developed containing ibuprofen in the form of orally disintegrating tablets. To prevent bitter taste and side effects of the drug, the drug was associated with Phospholipon 80H, a saturated lecithin, by wet granulation. The granules were then coated using different film forming agents (Kollicoat SR 30, Amprac 01, Kollidon 90F, Eudragit RD 100) obtaining four lots 1-4. Coated granules were then formulated with a sweetener (Aspartame), a mannitol-based diluent (Pearlitol SD 200) and Kollidon CL (1-4K) or Explotab (1-4E) were added as superdisintegrants and compacted under low compression force. The eight lots of tablets, 1-4K and 1-4E, were assessed if suitable as oral disintegrating tablets by determination of a range of technological parameters. Wetting and disintegregation time matched with the requirements of EP IV Ed., for almost all these formulations. Dissolution profiles suggested that the combined action of the hydrophobic lecithin and the coating delay the release of the drug from tablets with respect to when it is free or in the form of simple granules. By an appropriate combination of excipients it was thus possible to obtain orally disintegrating tablets and a delayed release of ibuprofen using simple and conventional techniques.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Delayed-Action Preparations/chemistry , Drug Compounding/methods , Ibuprofen/administration & dosage , Ibuprofen/chemistry , Aspartame/administration & dosage , Chemistry, Pharmaceutical/methods , Drug Stability , Polymethacrylic Acids/chemistry , Polyvinyls/chemistry , Povidone/chemistry , Starch/analogs & derivatives , Starch/chemistry , Tablets , Thermogravimetry , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...